Diabetic Foot Insoles Market
Industry
- Automobile and Transportation
- Chemicals and Materials
- Consumer Goods
- Energy and Power
- Electronics and Semiconductor
- Food and Beverages
- Machinery and Equipment
- Pharma and Healthcare
- Service and Software
- Others
- Packaging
- ICT
- Technology
- Medical Devices and Consumables
- Agriculture
- Medical Care
- Aerospace and Defense
Diabetic Foot Insoles Market Size, Share & Analysis By Material Type (Gel-based Insoles, Foam-based Insoles, Leather Insoles), By Application (Preventive, Therapeutic), By Distribution Channel (Hospital Pharmacies, Retail Stores, Online Stores and Others), By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa), and Growth Forecast To 2032
Report ID: RV25894 | Published: Nov 2023 | Historical Period: 2018-2021 | Pages: 200 | Price: $3260| Industry: Pharma and Healthcare
Diabetic Foot Insoles Market Overview 2023:
The Global Diabetic Foot Insole Market is expected to register a robust revenue CAGR over the forecast period. This growth can be attributed to factors such as rising prevalence of diabetes, growing aging population, and increasing awareness about importance of foot care among diabetic patients.
Diabetic foot disease (DFD) is one of the most serious complications in patients with diabetes mellitus and is a leading global burden for the healthcare systems. It usually encompasses infection, ulceration, and bone destruction of the foot of a diabetic person. Some common issues associated with diabetic foot include neuropathy, peripheral arterial disease, foot ulcers, Charcot foot, and foot deformities. Thus, to avoid these issues and improve overall foot health, regular foot inspection, maintenance of foot hygiene, and wearing proper footwear is of utmost importance.
Diabetic foot insoles are one of the most common and useful tools used to prevent as well as manage diabetic foot complications. These foot insoles also called orthotic insoles or diabetic shoe inserts provide better arch support and help with enhanced comfort and better circulation. Diabetic foot insoles have extra cushioning to provide shock absorption and reduce pressure on the feet. In addition, many insoles have good moisture-wicking properties that help to keep the feet dry and prevent bacterial and fungal growth. However, these foot insoles are costly. The sales might decrease due to lower purchasing power, especially in the regions with lower economic resources.
Graphical Overview:
Key Takeaways:
Rapid Advancements in Diabetic Foot Insoles:
As the prevalence of diabetes and risks of diabetic foot are on the rise, manufacturers are heavily investing in developing innovative diabetic foot insoles with enhanced features such as pressure sensors, temperature control, and high-quality material. This can result in enhancing the effectiveness of foot care and contribute to overall market growth.
Limited Reimbursement Policies and Availability of Alternative Treatments:
Though diabetic foot insoles are widely in use, many healthcare systems may have limited reimbursement policies for medical devices like foot insoles. This may hamper the overall market growth during the forecast period.
Market Opportunities:
The rising risks of diabetic foot ulcers and other complications and growing awareness about importance of foot care among diabetic patients is expected to open new opportunities for market players to expand their product base. Diabetic foot insole manufacturers can collaborate and partner with healthcare providers or diabetic management programs to expand their presence and product visibility.
Type Outlook:
Based on type, the global market is segmented into gel-based insoles, foam-based insoles, and leather insoles. The gel-based insoles segment is expected to register rapid revenue CAGR over the forecast period. Factors such as rising prevalence of diabetes, high preference for gel-based foot insoles due to better cushioning, shock absorption, even weight distribution, arch support, and temperature regulation, and high focus on increasing production of gel-based foot insoles to cater to the rising demand.
Application Outlook:
Among the application segments, the preventive segment is expected to account for a significantly larger revenue share between 2023 and 2032 due to factors like rising incidence of diabetes and risks associated with diabetic foot, growing awareness about importance of diabetic foot insole for preventive purposes, and high usage of preventive insoles for reducing risks of developing foot problems and ulcer prevention.
Distribution Channel Outlook:
The global market is segmented into hospital pharmacies, retail stores, online stores, and others based on distribution channels. Among these, the online stores segment revenue is expected to expand at a rapid growth rate throughout the forecast period. This growth can be attributed to rapidly growing e-commerce sector, presence of reputed online retailers, high preference for online purchases due to better pricing, availability of various types of products along with product review, accessibility to price comparison, and easy return policy.
Regional Outlook:
.JPG)
North America is expected to account for largest revenue share during the forecast period owing to increasing prevalence of diabetes across the region, rapid technological advancements, presence of well-developed medical services and infrastructure, and growing demand for advanced foot care devices for diabetic patients, and high adoption of smart insoles. In addition, the leading diabetic foot insole manufacturers in this region are focused on developing more enhanced products catering to regulatory standards and approvals. This is also expected to drive North America market growth during the forecast period.
Europe market is expected to account for the second-largest revenue share in the global market. This growth can be attributed to factors such as high prevalence of diabetes, rising awareness about importance of foot care and foot insole among diabetic patients, and rapid adoption of advanced technologies. In addition, improved healthcare infrastructure, rising availability of advanced medical facilities, and increasing investments in R&D activities are expected to boost market growth in Europe.
Report Coverage:
| Report Details | Outcome |
| Base Year for Estimation | 2022 |
| Historical Data | 2018-2021 |
| Forecast Period | 2023-2032 |
| Segments Covered: | Material Type, Appliccation and Region |
| By Material Type | Gel-based Insoles, Foam-based Insoles, Leather Insoles |
| By Application | Preventive, Therapeutic |
| By Distribution Channel | Hospital Pharmacies, Retail Stores, Online Stores and Others |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Country Scope | United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, Southeast Asia, India, Mexico, Brazil, Saudi Arabia, UAE, Turkey |
| Qualitative Info | •Value Chain Analysis •Pricing Analysis •Regional Outlook •Market Trends •Market Share Analysis •Competition Analysis •Technological Advancements |
| Key Players | Bauerfeind AG, Superfeet Worldwide, Inc., Dr. Scholl’s, Aertex Worldwide, Inc., Sidas SAS, Orpyx Medical Technologies, Inc., New Balance Athletics, Inc., Footbalance System Ltd., PediFix Footcare Company, Sorbothane, Inc., Hanger, Inc., Mile High Orthotics Lab, Capron Podologie, Corazza, DARCO International |
| Customization Scope | 10 Hours of Free Customization and Expert Consultation |
Competitive Landscape:
The global Diabetic Foot Insoles market is extremely competitive, comprising several regional and global level key players. Leading key players are focused on adopting various strategic alliances like mergers and acquisitions, partnerships, joint ventures, collaborations, and product launches to maintain their global position and enhance their product offerings. They are also focused on innovation, and scalability, and are adapting to evolving technology trends and consumer needs.
Some Leading Market Companies Listed in the Report:
- Bauerfeind AG
- Superfeet Worldwide, Inc.
- Scholl’s
- Aertex Worldwide, Inc.
- Sidas SAS
- Orpyx Medical Technologies, Inc.
- New Balance Athletics, Inc.
- Footbalance System Ltd.
- PediFix Footcare Company
- Sorbothane, Inc.
- Hanger, Inc.
- Mile High Orthotics Lab
- Capron Podologie
- Corazza
- DARCO International
Diabetic Foot Insoles Industry Recent Developments:
- In June 2023, Actics Medical launched custom smart insoles to help prevent diabetic foot ulcers.
- In December 2019, Orpyx Medical Technologies, Inc. announced the launch of Orpyx SI Sensory Insoles capable of remote patient monitoring to prevent diabetic foot ulcers.
The global Diabetic Foot Insoles Market has been segmented based on Material Type, Application, Distribution Channel, and Region:
By Material Type:
- Gel-based Insoles
- Foam-based Insoles
- Leather Insoles
By Application:
- Preventive
- Therapeutic
By Distribution Channel:
- Hospital Pharmacies
- Retail Stores
- Online Stores
- Others
By Region:
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Asia Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Frequently Asked Questions!
- Bauerfeind AG
- Superfeet Worldwide, Inc.
- Scholl’s
- Aertex Worldwide, Inc.
- Sidas SAS
- Orpyx Medical Technologies, Inc.
- New Balance Athletics, Inc.
- Footbalance System Ltd.
- PediFix Footcare Company
- Sorbothane, Inc.
- Hanger, Inc.
- Mile High Orthotics Lab
- Capron Podologie
- Corazza
- DARCO International
To Learn More About This Report
Our Clients
